Photo by sxy_selia from unsplash
Continuous levodopa‐carbidopa intestinal gel (LCIG) diminishes daily “off” time and dyskinesia in patients with advanced Parkinson′s disease (PD). Complications are common with percutaneous endoscopic gastrostomy with a jejunal extension tube… Click to show full abstract
Continuous levodopa‐carbidopa intestinal gel (LCIG) diminishes daily “off” time and dyskinesia in patients with advanced Parkinson′s disease (PD). Complications are common with percutaneous endoscopic gastrostomy with a jejunal extension tube (PEG‐J).
Keywords:
levodopa carbidopa;
carbidopa intestinal;
parkinson disease;
advanced parkinson;
intestinal gel
Journal Title: Brain and Behavior
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Brain and Behavior
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!